Effectiveness of COVID-19 Vaccines in Lung Cancer Patients: Navigating Challenges During the Omicron Variant Surge
-
By
-
Seyed M. Hosseini-Moghaddam
-
Sarah Swayze
-
Jeffrey C. Kwong
-
Frances A. Shepherd
-
February 6, 2026
-
0 min
Top Institutions in Pulmonary
Brief introduction explaining scope and methodology.
-
#1
Memorial Sloan Kettering Cancer Center
New York, NY
Key Differentiators
- Thoracic Oncology
- Infectious Diseases
- Epidemiology
-
#2
Dana-Farber Cancer Institute
Boston, MA
Key Differentiators
- Thoracic Oncology
- Immunology
- Infectious Diseases
-
#3
University of Texas MD Anderson Cancer Center
Houston, TX
Key Differentiators
- Thoracic Oncology
- Clinical Epidemiology
- Infectious Diseases
-
#4
Johns Hopkins University School of Medicine
Baltimore, MD
Key Differentiators
- Thoracic Oncology
- Infectious Diseases
- Public Health
-
#5
Vall d'Hebron Institute of Oncology (VHIO)
Barcelona, Catalonia
Key Differentiators
- Thoracic Oncology
- Clinical Research
- Infectious Diseases
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.